A searchable database of core laboratory facilities. Core Facilities

Tumor Imaging Metrics Core Facility (DF/HCC)

Director: Harris, Gordon J., Ph.D.; Van Den Abbeele, Annick D., M.D.

Location: 25 New Chardon Street Suite 501, Boston, MA 02114

Core Summary:

The Tumor Imaging Metrics Core (TIMC), co-Directed by Annick D. Van den Abbeele, MD (DFCI) and Gordon J. Harris, PhD (MGH), is a shared resource that was founded in 2004 to provide standardized, longitudinal tumor metrics for patients enrolled in oncologic clinical trials across the five Harvard teaching hospitals of the DF/HCC. The ordering, communication, workflow, results reporting, electronic signatures, audit trails, criteria conformance, and chargeback billing are all managed through a web-based informatics platform, Precision Imaging Metrics, developed by TIMC, which is currently in use at six NCI-designated Cancer Centers around the country. Clinical trials imaging assessment results are provided in time for review at the point of care in as little as one hour after completion of scanning. TIMC currently manages over 1,000 active clinical trials and performs over 12,000 image assessments per year for Partners and DF/HCC investigators. The mission of the Tumor Imaging Metrics Core (TIMC) is to provide standardized, consistent, longitudinal radiological measurements to evaluate therapeutic response for DF/HCC clinical trials.

The TIMC -

* Makes reliable, quantitative, longitudinal measurements (such as RECIST, Lugano, irRC, RANO,
standardized uptake value SUV etc.) of lesions from serial MRI, CT, PET, and PET/CT scan images
* Presents results of analyses on a password-protected secure web-based report
* Provides an independent service, with verifiable measurement of treatment response for patients enrolled in cancer center trials
* Serves as a centralized, computerized resource to facilitate efficient internal or external auditing

Institutions:
  • Beth Israel Deaconess Medical Center
  • Boston Children's Hospital
  • Brigham and Women's Hospital
  • Dana-Farber/Harvard Cancer Center
  • Dana-Farber Cancer Institute
  • Massachusetts General Hospital
  • Massey Cancer Center
Personnel/Contact Information:

Director: Harris, Gordon J., Ph.D.
Phone: (617) 726-9464
Email

Director: Van Den Abbeele, Annick D., M.D.
Phone: (617) 632-2595
Email

Member: Basinsky, Gina
Email

Member: General Inquiries
Email

Facilities and Equipment:

Location of Core: 25 New Chardon Street Suite 501, Boston, MA 02114

Major Equipment:

  • HERMES workstation
  • Merge Healthcare eFilm workstation
  • Precision Imaging Metrics Manager
  • Vitrea workstation
Services:
  • Consultation services for image-based protocol and image analysis design

  • Image scan aggregation and management service

  • Imaging Assessment Criteria for Oncology Clinical Trials

    3D Volume
    RECIST 1.0
    RECIST 1.1
    mRECIST for HCC
    mRECIST for Mesothelioma
    mRECIST (based on irRC)
    irRC
    PCWG2 + RECIST 1.0
    PCWG2 + RECIST 1.1
    PCWG 3
    Cheson (1999)
    Revised Cheson (2007)
    Lugano (2015)
    Lymphoma PET SUVmax
    Deauville (PET)
    IWCLL
    IWRC
    IMWG (for multiple myeloma)
    IPCG (radiological assessment only)
    ISCL
    MacDonald
    RANO
    Choi
    WHO
    PET SUV

  • Quality Control

    For site review, the TIMC paradigm utilizes one central reader per radiologic exam (single read). The central reader will be randomly assigned and cannot be selected by trial staff based on site location.

    A mediation process has been established in the instance that the central review is felt to be discordant with clinical assessment. Trial staff should file a request for mediation with the TIMC Help Desk (tumormetrics@partners.org) which will trigger a review by a blinded, independent reviewer at a site where the patient is not enrolled.

    A randomly selected subset of imaging studies are reviewed by dedicated TIMC staff to ensure that documentation was made to justify discordance between central radiology and clinical reviews. Additionally, data are reviewed to ensure appropriate disease was selected at baseline and that follow-up assessments were rendered according to established criteria.

  • Radiology reviewer training

    Radiologists and Image Analysts are trained and certified as proficient in established response assessment criteria and clinical research principles.

  • Reporting and database management service of radiological data for clinical trials

    Clinical trial staff can access the secure, password-protected website -any scan, anytime, anywhere- to request scan assessments and view results, including annotated images and graphs.

  • Standardized lesion measurement

    Standardized, longitudinal image measurement of radiological scans for oncology clinical trials.


Departmental Web Link(s):

Last updated: 2017-04-03T07:54:50.685-05:00